GTMB 7 - Gene Therapy & Molecular Biology

Cai et al: Lung cancer gene therapyTakigawa M, Nishida Y, Suzuki F, Kishi J, Yamashita K,Hayakawa T (1990) Induction of angiogenesis in chick yolksacmembrane by polyamines and its inhibition by tissueinhibitors of metalloproteinases (TIMP and TIMP-2).Biochem Biophys Res Commun 171:1264–1271.Tanaka M, Inase N, Miyake S, Yoshizawa Y (2001) Neuronspecific enolase promoter for suicide gene therapy in smallcell lung carcinoma. Anticancer Res 21, 291-294Tanaka T, Cao Y, Folkman J, Fine HA. (1998) Viral vectortargetedantiangiogenic gene therapy utilizing an angiostatincomplementary DNA Cancer Res 58, 3362-3369Tango Y, Fujiwara T, Itoshima T, Takata Y, Katsuda K, Uno F,Ohtani S, Tani T, Roth JA, Tanaka N (2002) Adenovirusmediatedp14ARF gene transfer cooperates with Ad5CMVp53to induce apoptosis in human cancer cells. Hum GeneTher 13, 1373-1382Thiery J, Dorothee G, Haddada H, Echchakir H, Richon C,Stancou R, Vergnon I, Benard J, Mami-Chouaib F, ChouaibS (2003) Potentiation of a tumor cell susceptibility toautologous CTL killing by restoration of wild-type p53function. J Immunol 170, 5919-5926Tran PL, Vigneron JP, Pericat D, Dubois S, Cazals D, Hervy M,DeClerck YA, Degott C, Auclair C (2003) Gene therapy forhepatocellular carcinoma using non-viral vectors composedof bis guanidinium-tren-cholesterol and plasmids encodingthe tissue inhibitors of metalloproteinases TIMP-2 andTIMP-3. Cancer Gene Ther 10, 435-444Trudeau C, Yuan S, Galipeau J, Benlimame N, Alaoui-JamaliMA, Batist G (2001) A novel parasite-derived suicide genefor cancer gene therapy with specificity for lung cancer cells.Hum Gene Ther 12, 1673-1680.Tseng JF, Farnebo FA, Kisker O, Becker CM, Kuo CJ, FolkmanJ, Mulligan RC (2002) Adenovirus-mediated delivery of asoluble form of the VEGF receptor Flk1 delays the growth ofmurine and human pancreatic adenocarcinoma in mice.Surgery 132, 857-865.Unfer RC, Hellrung D, Link CJ Jr (2003) Immunity to the α(1,3)galactosyl epitope provides protection in micechallenged with colon cancer cells expressing α(1,3)galactosyl-transferase: a novel suicide gene for cancergene therapy. Cancer Res 63, 987-993.Usui K, Saijo Y, Narumi K, Koyama S, Maemondo M, KikuchiT, Tazawa R, Hagiwara K, Ishibashi Y, Ohta S, Nukiwa T(2003) N-terminal deletion augments the cell-death-inducingactivity of BAX in adenoviral gene delivery to nonsmall celllung cancers. Oncogene 22, 2655-2663von Mehren M, Arlen P, Gulley J, Rogatko A, Cooper HS,Meropol NJ, Alpaugh RK, Davey M, McLaughlin S, BeardMT, Tsang KY, Schlom J, Weiner LM (2001) The influenceof granulocyte macrophage colony-stimulating factor andprior chemotherapy on the immunological response to avaccine (ALVAC-CEA B7.1) in patients with metastaticcarcinoma. Clin Cancer Res 7, 1181-1191Wei YQ, Huang MJ, Yang L, Zhao X, et al (2001) Immunogenetherapy of tumors with vaccine based on Xenopushomologous vascular endothelial growth factor as a modelantigen. Proc Natl Acad Sci U S A 98, 11545-11550.Wei YQ, Wang QR, Zhao X, Yang L, et al (2000)Immunotherapy of tumors with xenogeneic endothelial cellsas a vaccine Nat Med 6, 1160-1166Wiewrodt R, Amin K, Kiefer M, Jovanovic VP, Kapoor V, ForceS, Chang M, Lanuti M, Black ME, Kaiser LR, Albelda SM(2003) Adenovirus-mediated gene transfer of enhancedHerpes simplex virus thymidine kinase mutants improvesprodrug-mediated tumor cell killing. Cancer Gene Ther 10,353-364Wilczynska U, Kucharska A, Szary J, Szala S (2001) Combineddelivery of an antiangiogenic protein (angiostatin) and animmunomodulatory gene (interleukin-12) in the treatment ofmurine cancer. Acta Biochim Pol 48, 1077-1084Wroblewski JM, Bixby DL, Borowski C, Yannelli JR (2001)Characterization of human non-small cell lung cancer(NSCLC) cell lines for expression of MHC, co-stimulatorymolecules and tumor-associated antigens Lung Cancer 33,181-194Xu RA, Sun X, Tse LY, Li H, Chan PC, Xu S, Xiao W, KungHF, Krissansen GW, Fan ST (2003) Long-term expression ofangiostatin suppresses metastatic liver cancer in mice.Hepatology 37, 1451-1460.Xu RA, Li H., Tse, LY, Kung, H., Lu H, Lam SLDiabetes GeneThreapy: Potential and Challenges (2003) Curr Gene Ther 365-83Yamanaka R, Zullo SA, Ramsey J, Onodera M, Tanaka R,Blaese M, Xanthopoulos KG (2001) Induction of therapeuticantitumor antiangiogenesis by intratumoral injection ofgenetically engineered endostatin-producing Semliki Forestvirus Cancer Gene Ther 8, 796-802Yang E, Zha J, Jockel J, Boise LH, Thompson CB, Korsmeyer SJ(1995) Bad, a heterodimeric partner for Bcl-XL and Bcl-2,displaces Bax and promotes cell death. Cell 80, 285-291Yatabe Y, Masuda A, Koshikawa T, Nakamura S, Kuroishi T,Osada H, Takahashi T, Mitsudomi T, Takahashi T (1998)p27KIP1 in human lung cancers: differential changes insmall cell and non-small cell carcinomas. Cancer Res 58,1042-1047Yin C, Knudson CM, Korsmeyer SJ, Van Dyke T (1997) Baxsuppresses tumorigenesis and stimulates apoptosis in vivo.Nature 385, 637-640Yoshida S, Fukumoto S, Kawaguchi H, Sato S, Ueda R,Furukawa K (2001) Ganglioside G(D2) in small cell lungcancer cell lines: enhancement of cell proliferation andmediation of apoptosis. Cancer Res 61, 4244-4252Yoshimura A, Gemma A, Hosoya Y, Komaki E, Hosomi Y,Okano T, Takenaka K, Matuda K, Seike M, Uematsu K,Hibino S, Shibuya M, Yamada T, Hirohashi S, Kudoh S(2003) Increased expression of the LGALS3 (Galectin 3)gene in human non-small-cell lung cancer. GenesChromosomes Cancer 37, 159-164Zhang Y, Yu J, Unni E, Shao TC, Nan B, Snabboon T, Kasper S,Andriani F, Denner L, Marcelli M (2002) Monogene andPolygene Therapy for the Treatment of ExperimentalProstate Cancers by Use of Apoptotic Genes bax and badDriven by the Prostate-Specific Promoter ARR(2)PB. HumGene Ther 13, 2051-2064Zhang YA, Nemunaitis J, Scanlon KJ, Tong AW (2000) Antitumorigeniceffect of a K-ras ribozyme against human lungcancer cell line heterotransplants in nude mice Gene Ther 7,2041-2045Dr. Ruian Xu272